As the data demonstrates, there is a gap between the amount procured and the amount required for the full implementation of the active management of the third stage of labor (AMTSL) as only 69% of the theoretical need is being made available at the central level. In addition, despite the guidelines stating that oxytocin should be first line, a large, disproportionate amount of ergometrine is being procured.